IL129135A0 - 3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds - Google Patents

3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds

Info

Publication number: IL129135A0
Authority: IL; Israel
Prior art keywords: alkoxyisoxazol; substituted; carboxylic acid; acid compounds; amino carboxylic
Prior art date: 1996-10-04

Application number

IL12913597A

Other languages

English (en)

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-04

Filing date

1997-10-03

Publication date

2000-02-17

1997-10-03 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2000-02-17 Publication of IL129135A0 publication Critical patent/IL129135A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

IL12913597A 1996-10-04 1997-10-03 3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds IL129135A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK109296		1996-10-04
PCT/DK1997/000426 WO1998015542A1 (en)	1996-10-04	1997-10-03	3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds

Publications (1)

Publication Number	Publication Date
IL129135A0 true IL129135A0 (en)	2000-02-17

Family

ID=8100908

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12913597A IL129135A0 (en)	1996-10-04	1997-10-03	3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds

Country Status (26)

Country	Link
US (1)	US6200999B1 (zh)
EP (1)	EP0934286B1 (zh)
JP (1)	JP2001501630A (zh)
KR (1)	KR20000048908A (zh)
CN (1)	CN1238766A (zh)
AR (1)	AR008880A1 (zh)
AT (1)	ATE230734T1 (zh)
AU (1)	AU733004B2 (zh)
BG (1)	BG103348A (zh)
BR (1)	BR9712198A (zh)
CA (1)	CA2268028C (zh)
CZ (1)	CZ116899A3 (zh)
DE (1)	DE69718338T2 (zh)
EA (1)	EA001625B1 (zh)
ES (1)	ES2189978T3 (zh)
HU (1)	HUP0000084A3 (zh)
IL (1)	IL129135A0 (zh)
IS (1)	IS5009A (zh)
NO (1)	NO312961B1 (zh)
NZ (1)	NZ334798A (zh)
PL (1)	PL332553A1 (zh)
SK (1)	SK42899A3 (zh)
TR (1)	TR199900724T2 (zh)
UA (1)	UA52698C2 (zh)
WO (1)	WO1998015542A1 (zh)
ZA (1)	ZA978877B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA73749C2 (en) *	1999-11-01	2005-09-15		Diarylenines
US6495582B1 (en) *	2000-09-15	2002-12-17	Vertex Pharmaceuticals Incorporated	Isoxazole compositions useful as inhibitors of ERK
US20040106794A1 (en) *	2001-04-16	2004-06-03	Schering Corporation	3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
UA78529C2 (en)	2001-10-10	2007-04-10	Wyeth Corp	Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain
US20040152694A1 (en) *	2003-02-04	2004-08-05	Istvan Kurucz	Methods and compositions for treating inflammatory disorders of the airways
AU2004230895B2 (en)	2003-04-09	2010-09-09	Wyeth	Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as N-methyl-D-aspartate (NMDA) receptor antagonists
TW200514775A (en)	2003-10-22	2005-05-01	Wyeth Corp	Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
CA2625301A1 (en) *	2005-10-11	2007-04-19	F. Hoffmann-La Roche Ag	Isoxazole derivatives
CN102066345B (zh) *	2008-01-16	2013-07-17	生物科技研究有限公司	*唑烷衍生物作为nmda拮抗剂
EP2338492A1 (en)	2009-12-24	2011-06-29	Universidad del Pais Vasco	Methods and compositions for the treatment of alzheimer
TW201609719A (zh)	2014-05-28	2016-03-16	美國禮來大藥廠	作為ＴＡＲＰ－γ８依賴性ＡＭＰＡ受體拮抗劑之６－經取代－３Ｈ－１，３－苯并噻唑－２－酮化合物
KR102157528B1 (ko) *	2016-01-21	2020-09-21	아구로카네쇼 가부시키가이샤	2-아미노니코틴산 벤질에스테르 유도체의 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0456519B1 (en)	1990-05-11	1994-07-13	Sankyo Company Limited	Piperidyloxy- and quinuclidinyloxy- isoxazole derivatives, their preparation and their therapeutic use
WO1994010145A1 (en)	1992-10-23	1994-05-11	Merck Sharp & Dohme Limited	Dopamine receptor subtype ligands
DK124393D0 (da) *	1993-11-03	1993-11-03	Lundbeck & Co As H	Compounds

1997
- 1997-03-10 UA UA99042300A patent/UA52698C2/uk unknown
- 1997-10-03 AT AT97942821T patent/ATE230734T1/de not_active IP Right Cessation
- 1997-10-03 BR BR9712198-3A patent/BR9712198A/pt unknown
- 1997-10-03 EA EA199900358A patent/EA001625B1/ru not_active IP Right Cessation
- 1997-10-03 DE DE69718338T patent/DE69718338T2/de not_active Expired - Fee Related
- 1997-10-03 AU AU44517/97A patent/AU733004B2/en not_active Ceased
- 1997-10-03 PL PL97332553A patent/PL332553A1/xx unknown
- 1997-10-03 HU HU0000084A patent/HUP0000084A3/hu unknown
- 1997-10-03 SK SK428-99A patent/SK42899A3/sk unknown
- 1997-10-03 EP EP97942821A patent/EP0934286B1/en not_active Expired - Lifetime
- 1997-10-03 NZ NZ334798A patent/NZ334798A/en unknown
- 1997-10-03 AR ARP970104586A patent/AR008880A1/es not_active Application Discontinuation
- 1997-10-03 CA CA002268028A patent/CA2268028C/en not_active Expired - Fee Related
- 1997-10-03 CN CN97180167A patent/CN1238766A/zh active Pending
- 1997-10-03 WO PCT/DK1997/000426 patent/WO1998015542A1/en not_active Application Discontinuation
- 1997-10-03 TR TR1999/00724T patent/TR199900724T2/xx unknown
- 1997-10-03 CZ CZ991168A patent/CZ116899A3/cs unknown
- 1997-10-03 IL IL12913597A patent/IL129135A0/xx unknown
- 1997-10-03 ZA ZA9708877A patent/ZA978877B/xx unknown
- 1997-10-03 JP JP10517096A patent/JP2001501630A/ja active Pending
- 1997-10-03 KR KR1019990702938A patent/KR20000048908A/ko not_active Application Discontinuation
- 1997-10-03 US US09/269,356 patent/US6200999B1/en not_active Expired - Fee Related
- 1997-10-03 ES ES97942821T patent/ES2189978T3/es not_active Expired - Lifetime
1999
- 1999-03-20 BG BG103348A patent/BG103348A/xx unknown
- 1999-03-23 IS IS5009A patent/IS5009A/is unknown
- 1999-03-30 NO NO19991561A patent/NO312961B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0934286A1 (en)	1999-08-11
IS5009A (is)	1999-03-23
EP0934286B1 (en)	2003-01-08
EA001625B1 (ru)	2001-06-25
CN1238766A (zh)	1999-12-15
US6200999B1 (en)	2001-03-13
DE69718338D1 (de)	2003-02-13
BG103348A (en)	1999-11-30
AU4451797A (en)	1998-05-05
NO312961B1 (no)	2002-07-22
JP2001501630A (ja)	2001-02-06
KR20000048908A (ko)	2000-07-25
CZ116899A3 (cs)	1999-09-15
TR199900724T2 (xx)	1999-06-21
WO1998015542A1 (en)	1998-04-16
HUP0000084A3 (en)	2001-12-28
NO991561D0 (no)	1999-03-30
ATE230734T1 (de)	2003-01-15
AR008880A1 (es)	2000-02-23
HUP0000084A2 (hu)	2000-06-28
EA199900358A1 (ru)	1999-10-28
NO991561L (no)	1999-06-04
UA52698C2 (uk)	2003-01-15
BR9712198A (pt)	1999-08-31
PL332553A1 (en)	1999-09-13
ZA978877B (en)	1998-04-17
SK42899A3 (en)	1999-08-06
AU733004B2 (en)	2001-05-03
CA2268028A1 (en)	1998-04-16
ES2189978T3 (es)	2003-07-16
NZ334798A (en)	2000-06-23
DE69718338T2 (de)	2003-10-16
CA2268028C (en)	2003-03-18

Publication	Publication Date	Title
GB9626637D0 (en)	1997-02-12	Percarboxyilic acid solutions
HU9801045D0 (en)	1998-07-28	Substituted diamino-carboxylic acids
HU9801044D0 (en)	1998-07-28	Sulfonyl-amino-carboxylic acid derivatives
HUP0003881A3 (en)	2001-04-28	Amidocarboxylic acid derivatives
HUP9902645A3 (en)	1999-12-28	Fused-ring carboxylic acid derivatives
HUP0600401A3 (en)	2010-05-28	Naphtyridine carboxylic acid derivative salt
EP0801644A4 (en)	2001-03-07	POLYARYLCARBAMOYLAZADIOQUE ACIDS AND CARBAMOYLALCANEDIO QUES
ZA9810298B (en)	1999-05-18	Isothiazole carboxylic acid derivatives
NZ286622A (en)	1997-08-22	Fluorophenylalkenylcarboxylic acid guanidides
IL129135A0 (en)	2000-02-17	3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds
HU9500728D0 (en)	1995-04-28	5-vinyl- and 5-ethinyl-quinolon- and -naphtiridone-carboxylig acids
EP0774965A4 (en)	1997-10-29	PHENOXYPHENYLACETIC ACID DERIVATIVES
HU9503309D0 (en)	1996-01-29	Carboxylic acid amide benzothiophene-s-oxides
IL135967A (en)	2005-05-17	Jasmonic acid compounds and process for the preparation thereof
ZA948631B (en)	1995-07-10	5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
ZA9510888B (en)	1996-06-24	3-aryl-tetronic acid derivatives
ZA981472B (en)	1998-08-19	Process for the manufacture of carboxylic acids
GR3030629T3 (en)	1999-10-29	Clavulanic acid salts
HUP9802329A3 (en)	1999-04-28	Carboxylic acid derivatives
HU9700148D0 (en)	1997-03-28	Trifluoromethylquinolinecarboxylic acid derivative
IL135639A0 (en)	2001-05-20	Novel methylenebisphosphonic acid derivatives
SI0934286T1 (en)	2003-06-30	3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
AU5319898A (en)	1998-06-10	Glyoxylic acid amides
AU8214498A (en)	1999-01-04	Glyoxylic acid amides
ZA955966B (en)	1996-02-21	New N1-miscellaneous 6-fluoro-8-difluoromethoxy-substituted quinolonecarboxylic acids